NRIX

Nurix Therapeutics Inc

May 15 • 04:00PM ET

15.85

-0.15 -0.91 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR ARVN CCCC GLUE RLAY

| Held by: VTI XBI IWM ARKG VXF IWN IBB VTWO SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.86%	Shs Outstand	103.40M	Perf Week	-4.03%
Market Cap	1.64B	Forward P/E	-	EPS next Y	-2.83	Insider Trans	-2.02%	Shs Float	97.38M	Perf Month	-5.00%
Enterprise Value	1.16B	PEG	-	EPS next Q	-0.72	Inst Own	106.06%	Short Float	19.72%	Perf Quarter	1.63%
Income	-295.28M	P/S	22.84	EPS this Y	3.26%	Inst Trans	34.12%	Short Ratio	18.00	Perf Half Y	30.28%
Sales	71.78M	P/B	3.41	EPS next Y	3.94%	ROA	-47.20%	Short Interest	19.20M	Perf YTD	-16.42%
Book/sh	4.65	P/C	3.03	EPS next 5Y	9.58%	ROE	-61.40%	52W High	22.50 -29.53%	Perf Year	67.60%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 93.47%	Perf 3Y	45.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	4.15% 4.44%	Perf 5Y	-38.90%
Dividend TTM	-	EV/Sales	16.12	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	0.77	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	44.07	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	-4.06%	Beta	1.84	Target Price	30.18
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	-0.70%	Rel Volume	0.94	Prev Close	16.00
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	10.60%	Avg Volume	1.07M	Price	15.85
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	998,956	Change	-0.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)